Literature DB >> 11176575

Purified protein derivative anergy in Kawasaki disease.

T R Kollmann1, E J Klein, C B Stefanelli, E K Marcuse.   

Abstract

It was previously reported from Italy that all patients with Kawasaki disease had a positive tuberculin intradermal test. In this study from Seattle, WA, nine patients with Kawasaki disease showed no reaction to intradermal tuberculin. The difference in results might be caused by the different tuberculin products.

Entities:  

Mesh：

Year:  2001        PMID： 11176575     DOI： 10.1097/00006454-200101000-00018

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


  3 in total

1.  Tuberculin positivity in Kawasaki disease: an unusual occurrence.

Authors:  Madhusudan S; Surjit Singh; Deepti Suri; Nabaneeta Dash; Anju Gupta
Journal:  Indian J Pediatr       Date:  2014-02-14       Impact factor: 1.967

2.  Common variants in CASP3 confer susceptibility to Kawasaki disease.

Authors:  Yoshihiro Onouchi; Kouichi Ozaki; Jane C Buns; Chisato Shimizu; Hiromichi Hamada; Takafumi Honda; Masaru Terai; Akihito Honda; Takashi Takeuchi; Shoichi Shibuta; Tomohiro Suenaga; Hiroyuki Suzuki; Kouji Higashi; Kumi Yasukawa; Yoichi Suzuki; Kumiko Sasago; Yasushi Kemmotsu; Shinichi Takatsuki; Tsutomu Saji; Tetsushi Yoshikawa; Toshiro Nagai; Kunihiro Hamamoto; Fumio Kishi; Kazunobu Ouchi; Yoshitake Sato; Jane W Newburger; Annette L Baker; Stanford T Shulman; Anne H Rowley; Mayumi Yashiro; Yoshikazu Nakamura; Keiko Wakui; Yoshimitsu Fukushima; Akihiro Fujino; Tatsuhiko Tsunoda; Tomisaku Kawasaki; Akira Hata; Yusuke Nakamura; Toshihiro Tanaka
Journal:  Hum Mol Genet       Date:  2010-04-27       Impact factor: 6.150

Review 3.  BCG: a vaccine with multiple faces.

Authors:  Marco Antonio Yamazaki-Nakashimada; Alberto Unzueta; Luisa Berenise Gámez-González; Napoleón González-Saldaña; Ricardo U Sorensen
Journal:  Hum Vaccin Immunother       Date:  2020-01-29       Impact factor: 3.452
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.